HIGHLIGHTS
- who: Ahmed F. Gabr from the University, Aswan, Egypt have published the research: Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema, in the Journal: (JOURNAL)
- what: Considering the high prevalence of DME and its challenging treatment, this study was conducted to investigate whether addition of topical bromfenac to the intravitreal ranibizumab would promote its efficacy compared with intravitreal ranibizumab only. In the present study, the need for reinjection was significantly less among patients in ranibizumab plus bromfenac group compared to those treated with ranibizumab alone.
SUMMARY
Diabetic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.